Cite
MLA Citation
R.J. Kwakman et al.. “Tolerability of the oral fluoropyrimidine S-1 after hand-foot syndrome-related discontinuation of capecitabine in Western cancer patients.” European journal of cancer, vol. 72, n.d., pp. S69–. http://access.bl.uk/ark:/81055/vdc_100041522134.0x00002e